A Functional, Nonfunctioning Retisert Implant

Abstract

The fluocinolone acetonide (Retisert™) implant is an approved therapy for chronic, posterior, non-infectious uveitis. Continued episodes of inflammation can occur in patients after device implantation and suspected Retisert™ malfunction has been previously reported. We report a case of a patient who continued to have inflammation after Retisert™ implantation, which subsided after device exchange with a normally functioning explant after detailed manufacturer analysis.

Keywords::

• drug-delivery device
• Retisert™
• Retisert™ malfunction
• uveitis

ACKNOWLEDGMENT

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.